Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is large cell neuroendocrine carcinoma of the lung?
Large cell neuroendocrine carcinoma sits at the aggressive end of the lung neuroendocrine family — the opposite of the slow bronchial carcinoids. It is a high-grade cancer whose cells divide rapidly and tend to spread early, so it is grouped with and often treated like small cell lung cancer, even though it can look like a non-small cell tumor on a biopsy. LCNEC is strongly associated with smoking and usually appears in older adults. Because it is uncommon and behaves unpredictably, expert pathology review and care at a center experienced with neuroendocrine tumors are important. When the cancer is caught early and confined to the lung, surgery (with chemotherapy afterward) or, for those who can't have surgery, radiation combined with chemotherapy offers the best chance of control. When it has spread, treatment centers on chemotherapy — typically the etoposide-and-platinum combination used for small cell lung cancer — now often paired with immunotherapy, while newer targeted approaches are being studied.
The main types
Doctors group large cell neuroendocrine carcinoma of the lung by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Pure LCNEC | The tumor is entirely large cell neuroendocrine carcinoma. Treated as an aggressive high-grade neuroendocrine cancer. |
| Combined LCNEC | Mixed with another lung cancer type, such as adenocarcinoma or squamous cell carcinoma. Treatment weighs both components. |
| Molecular subtypes | Research divides LCNEC into small-cell-like and non-small-cell-like genetic subtypes, which may help predict which chemotherapy works best — an active area of study. |
Staging, in plain terms
LCNEC is staged with the standard lung-cancer TNM system, but because it behaves like small cell lung cancer, doctors also think in practical terms of 'limited' disease (treatable with a focused plan) versus 'extensive' disease (widespread).
| Lung-cancer TNM (often grouped as limited vs. extensive) | What it generally means |
|---|---|
| Stage I–II (localized) | The tumor is confined to the lung, with limited or no nodal involvement. Surgery, usually followed by chemotherapy, gives the best chance of cure. |
| Stage III (locally advanced) | The cancer involves lymph nodes in the center of the chest. Treatment combines chemotherapy with radiation, sometimes with surgery in selected cases. |
| Stage IV (metastatic / extensive) | The cancer has spread beyond the chest. Treatment focuses on chemotherapy, often with immunotherapy, to control disease and prolong life. |
The standard of care
Large Cell Neuroendocrine Carcinoma of the Lung is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Surgery for early-stage disease
When LCNEC is confined to the lung, removing it surgically offers the best chance of cure, almost always followed by chemotherapy because the cancer spreads readily.
Chemotherapy (etoposide + platinum)
The small-cell-lung-cancer regimen of etoposide plus a platinum drug is the backbone for both adjuvant treatment after surgery and for advanced disease.
Chemoradiation for inoperable localized tumors
For locally advanced disease that can't be removed, radiation combined with chemotherapy is the standard, mirroring how locally advanced lung cancers are treated.
Immunotherapy & emerging targeted drugs
Adding immune checkpoint inhibitors to chemotherapy is increasingly used in advanced disease, and DLL3-targeted agents and other approaches are being tested in trials.
How radiation treatment works
Radiation damages the DNA inside cancer cells so they can no longer divide. Fast-growing cancers like LCNEC are often quite sensitive to it, which is why radiation — paired with chemotherapy — is a mainstay for localized tumors that can't be surgically removed. Modern image-guided machines shape the beam precisely to the tumor and limit dose to the healthy lung, heart, and spinal cord nearby. Treatment is painless, delivered as a series of short daily sessions, and leaves no radioactivity in your body.
The main ways radiation is delivered for large cell neuroendocrine carcinoma of the lung:
External-beam radiation (IMRT/SBRT)
Image-guided x-ray beams are shaped tightly around the tumor. For a small inoperable tumor, stereotactic body radiation (SBRT) delivers a few intense, precise sessions; for locally advanced disease, daily radiation is combined with chemotherapy.
Prophylactic cranial irradiation (selected cases)
Because neuroendocrine lung cancers can spread to the brain, low-dose preventive brain radiation is sometimes considered after a good response, as it is in small cell lung cancer — though its role in LCNEC is still being defined.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Updated management review of pulmonary LCNEC: A 2026 review summarizes that resectable LCNEC is treated with surgery plus small-cell-type adjuvant chemotherapy, advanced disease with etoposide-platinum chemotherapy increasingly combined with immunotherapy, while the roles of adjuvant radiation and preventive brain radiation remain under study.[1]
Clinical Lung Cancer, 2026 (S1525-7304(26)00003-3)
Molecular subtypes guiding therapy: Research dividing LCNEC into small-cell-like and non-small-cell-like genetic subtypes suggests these molecular profiles may predict which chemotherapy regimen works best, helping personalize treatment.[2]
Optimal treatment by molecular subtype, PMC12841917
Outcomes after definitive treatment: Single-center series of patients treated with surgery or chemoradiation report that aggressive multimodal therapy can achieve meaningful control of localized LCNEC, while metastatic disease carries a guarded prognosis.[3]
Definitive-treatment outcomes review, PMC12198915
Common questions
Is LCNEC the same as small cell lung cancer? Not exactly, but it behaves very similarly — it's aggressive and spreads early — so doctors often treat it with the same chemotherapy used for small cell lung cancer. Expert pathology review helps confirm the diagnosis, because LCNEC can be mistaken for other lung cancers.
Can it be cured? When LCNEC is found early and confined to the lung, surgery followed by chemotherapy offers a real chance of cure. Once it has spread, treatment focuses on controlling the disease and extending life rather than curing it, though new immunotherapy and targeted drugs are improving options.
Will I need radiation? It depends on the situation. Radiation combined with chemotherapy is standard when a localized tumor can't be removed surgically. It's also used to treat areas of spread or to ease symptoms, and preventive brain radiation is considered in selected cases.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.